Please login to read the full article.
Scrip Regulatory Affairs
Canada revises guideline on CTD use to facilitate submissions
10 August 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Canada consults on proposed changes to clinical trials guideline for drugs
- ICH to clarify E3 guideline on clinical study reports and alignment with CTD
- ICH outlines quality requirements for developing and manufacturing drug substances
- EU guidance could jeopardise confidentiality, says industry, but consumers want more openness
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
